APO Research
Talk to an analyst

APO RESEARCH · REPORT

Decitabine for Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Decitabine for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025197 pages

Choose your research edition.

Industry ResearchDecitabine for Injection Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Decitabine for Injection Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Decitabine for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decitabine for Injection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Decitabine for Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Decitabine for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Decitabine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Decitabine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Decitabine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Decitabine for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Decitabine for Injection include Astex Pharmaceuticals, Hansoh Pharmaceutical, Ingenus Pharmaceutical, Meitheal Pharmaceuticals, Otsuka US, Sagent Pharmaceuticals, Huiyu Pharmaceutical, Qilu Pharmaceutical and Xian Janssen Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Decitabine for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Decitabine for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Decitabine for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Decitabine for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Decitabine for Injection Segment by Company

Astex Pharmaceuticals

Hansoh Pharmaceutical

Ingenus Pharmaceutical

Meitheal Pharmaceuticals

Otsuka US

Sagent Pharmaceuticals

Huiyu Pharmaceutical

Qilu Pharmaceutical

Xian Janssen Pharmaceutical

Chia Tai Tianqing Pharmaceutical Group

Decitabine for Injection Segment by Type

50mg/Bottle

Other

Decitabine for Injection Segment by Application

Hospital

Clinic

Decitabine for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decitabine for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decitabine for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decitabine for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Decitabine for Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Decitabine for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Decitabine for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Decitabine for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Decitabine for Injection Industry Trends Table 2. Decitabine for Injection Industry Drivers Table 3. Decitabine for Injection Industry Opportunities and Challenges Table 4. Decitabine for Injection Industry Restraints Table 5. Global Decitabine for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Decitabine for Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Decitabine for Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Decitabine for Injection Sales Market Share by Manufacturers Table 9. Global Decitabine for Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Decitabine for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Decitabine for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Decitabine for Injection Manufacturers, Product Type & Application Table 13. Global Decitabine for Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Decitabine for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50mg/Bottle Table 17. Major Manufacturers of Other Table 18. Global Decitabine for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Decitabine for Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Decitabine for Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Decitabine for Injection Sales Market Share by Type (2021-2026) Table 22. Global Decitabine for Injection Sales Market Share by Type (2027-2032) Table 23. Global Decitabine for Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Decitabine for Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Decitabine for Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Decitabine for Injection Revenue Market Share by Type (2021-2026) Table 27. Global Decitabine for Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Decitabine for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Decitabine for Injection Sales by Application (2021-2026) & (K Units) Table 32. Global Decitabine for Injection Sales by Application (2027-2032) & (K Units) Table 33. Global Decitabine for Injection Sales Market Share by Application (2021-2026) Table 34. Global Decitabine for Injection Sales Market Share by Application (2027-2032) Table 35. Global Decitabine for Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Decitabine for Injection Revenue by Application (2021-2026) & (K Units) Table 37. Global Decitabine for Injection Revenue by Application (2027-2032) & (K Units) Table 38. Global Decitabine for Injection Revenue Market Share by Application (2021-2026) Table 39. Global Decitabine for Injection Revenue Market Share by Application (2027-2032) Table 40. Global Decitabine for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Decitabine for Injection Sales by Region (2021-2026) & (K Units) Table 42. Global Decitabine for Injection Sales Market Share by Region (2021-2026) Table 43. Global Decitabine for Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Decitabine for Injection Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Decitabine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Decitabine for Injection Sales by Country (2021-2026) & (K Units) Table 47. North America Decitabine for Injection Sales by Country (2027-2032) & (K Units) Table 48. Europe Decitabine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Decitabine for Injection Sales by Country (2021-2026) & (K Units) Table 50. Europe Decitabine for Injection Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Decitabine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Decitabine for Injection Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Decitabine for Injection Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Decitabine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Decitabine for Injection Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Decitabine for Injection Sales by Country (2027-2032) & (K Units) Table 57. Global Decitabine for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Decitabine for Injection Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Decitabine for Injection Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Decitabine for Injection Revenue Market Share by Region (2021-2026) Table 61. Global Decitabine for Injection Revenue Market Share by Region (2027-2032) Table 62. Astex Pharmaceuticals Company Information Table 63. Astex Pharmaceuticals Business Overview Table 64. Astex Pharmaceuticals Decitabine for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Astex Pharmaceuticals Decitabine for Injection Product Portfolio Table 66. Astex Pharmaceuticals Recent Development Table 67. Hansoh Pharmaceutical Company Information Table 68. Hansoh Pharmaceutical Business Overview Table 69. Hansoh Pharmaceutical Decitabine for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Hansoh Pharmaceutical Decitabine for Injection Product Portfolio Table 71. Hansoh Pharmaceutical Recent Development Table 72. Ingenus Pharmaceutical Company Information Table 73. Ingenus Pharmaceutical Business Overview Table 74. Ingenus Pharmaceutical Decitabine for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Ingenus Pharmaceutical Decitabine for Injection Product Portfolio Table 76. Ingenus Pharmaceutical Recent Development Table 77. Meitheal Pharmaceuticals Company Information Table 78. Meitheal Pharmaceuticals Business Overview Table 79. Meitheal Pharmaceuticals Decitabine for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Meitheal Pharmaceuticals Decitabine for Injection Product Portfolio Table 81. Meitheal Pharmaceuticals Recent Development Table 82. Otsuka US Company Information Table 83. Otsuka US Business Overview Table 84. Otsuka US Decitabine for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Otsuka US Decitabine for Injection Product Portfolio Table 86. Otsuka US Recent Development Table 87. Sagent Pharmaceuticals Company Information Table 88. Sagent Pharmaceuticals Business Overview Table 89. Sagent Pharmaceuticals Decitabine for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sagent Pharmaceuticals Decitabine for Injection Product Portfolio Table 91. Sagent Pharmaceuticals Recent Development Table 92. Huiyu Pharmaceutical Company Information Table 93. Huiyu Pharmaceutical Business Overview Table 94. Huiyu Pharmaceutical Decitabine for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Huiyu Pharmaceutical Decitabine for Injection Product Portfolio Table 96. Huiyu Pharmaceutical Recent Development Table 97. Qilu Pharmaceutical Company Information Table 98. Qilu Pharmaceutical Business Overview Table 99. Qilu Pharmaceutical Decitabine for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Qilu Pharmaceutical Decitabine for Injection Product Portfolio Table 101. Qilu Pharmaceutical Recent Development Table 102. Xian Janssen Pharmaceutical Company Information Table 103. Xian Janssen Pharmaceutical Business Overview Table 104. Xian Janssen Pharmaceutical Decitabine for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Xian Janssen Pharmaceutical Decitabine for Injection Product Portfolio Table 106. Xian Janssen Pharmaceutical Recent Development Table 107. Chia Tai Tianqing Pharmaceutical Group Company Information Table 108. Chia Tai Tianqing Pharmaceutical Group Business Overview Table 109. Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Product Portfolio Table 111. Chia Tai Tianqing Pharmaceutical Group Recent Development Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Decitabine for Injection Distributors List Table 115. Decitabine for Injection Customers List Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Decitabine for Injection Product Image Figure 2. Global Decitabine for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Decitabine for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Decitabine for Injection Sales (2021-2032) & (K Units) Figure 5. Global Decitabine for Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Decitabine for Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50mg/Bottle Image Figure 9. Other Image Figure 10. Global Decitabine for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Decitabine for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Decitabine for Injection Sales Market Share by Type (2021-2032) Figure 13. Global Decitabine for Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Decitabine for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Decitabine for Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Decitabine for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Decitabine for Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Decitabine for Injection Sales Market Share by Application (2021-2032) Figure 21. Global Decitabine for Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Decitabine for Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Decitabine for Injection Revenue Market Share by Application (2021-2032) Figure 24. North America Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Decitabine for Injection Sales Market Share by Country (2021-2032) Figure 26. U.S. Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Decitabine for Injection Sales Market Share by Country (2021-2032) Figure 31. Germany Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Decitabine for Injection Sales Market Share by Country (2021-2032) Figure 38. China Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Decitabine for Injection Sales Market Share by Country (2021-2032) Figure 46. Brazil Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Decitabine for Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Decitabine for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Decitabine for Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Decitabine for Injection Revenue (2021-2032) & (US$ Million) Figure 57. North America Decitabine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Decitabine for Injection Revenue (2021-2032) & (US$ Million) Figure 59. Europe Decitabine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Decitabine for Injection Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Decitabine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Decitabine for Injection Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Decitabine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Decitabine for Injection Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Decitabine for Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg/Bottle
  • Other
Applications
  • Hospital
  • Clinic
Companies covered
  • Astex Pharmaceuticals
  • Hansoh Pharmaceutical
  • Ingenus Pharmaceutical
  • Meitheal Pharmaceuticals
  • Otsuka US
  • Sagent Pharmaceuticals
  • Huiyu Pharmaceutical
  • Qilu Pharmaceutical
  • Xian Janssen Pharmaceutical
  • Chia Tai Tianqing Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Decitabine for Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Decitabine for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Decitabine for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Decitabine for Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Decitabine for Injection Market Dynamics
  1. 2.1 Decitabine for Injection Industry Trends
  2. 2.2 Decitabine for Injection Industry Drivers
  3. 2.3 Decitabine for Injection Industry Opportunities and Challenges
  4. 2.4 Decitabine for Injection Industry Restraints
3 Decitabine for Injection Market by Manufacturers
  1. 3.1 Global Decitabine for Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Decitabine for Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Decitabine for Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Decitabine for Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Decitabine for Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Decitabine for Injection Manufacturers, Product Type & Application
  7. 3.7 Global Decitabine for Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Decitabine for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Decitabine for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Decitabine for Injection Tier 1, Tier 2, and Tier 3
4 Decitabine for Injection Market by Type
  1. 4.1 Decitabine for Injection Type Introduction
  2. 4.1.1 50mg/Bottle
  3. 4.1.2 Other
  4. 4.2 Global Decitabine for Injection Sales by Type
  5. 4.2.1 Global Decitabine for Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Decitabine for Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Decitabine for Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Decitabine for Injection Revenue by Type
  9. 4.3.1 Global Decitabine for Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Decitabine for Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Decitabine for Injection Revenue Market Share by Type (2021-2032)
5 Decitabine for Injection Market by Application
  1. 5.1 Decitabine for Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Decitabine for Injection Sales by Application
  5. 5.2.1 Global Decitabine for Injection Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Decitabine for Injection Sales by Application (2021-2032)
  7. 5.2.3 Global Decitabine for Injection Sales Market Share by Application (2021-2032)
  8. 5.3 Global Decitabine for Injection Revenue by Application
  9. 5.3.1 Global Decitabine for Injection Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Decitabine for Injection Revenue by Application (2021-2032)
  11. 5.3.3 Global Decitabine for Injection Revenue Market Share by Application (2021-2032)
6 Global Decitabine for Injection Sales by Region
  1. 6.1 Global Decitabine for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Decitabine for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Decitabine for Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Decitabine for Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Decitabine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Decitabine for Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Decitabine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Decitabine for Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Decitabine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Decitabine for Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Decitabine for Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Decitabine for Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Decitabine for Injection Revenue by Region
  1. 7.1 Global Decitabine for Injection Revenue by Region
  2. 7.1.1 Global Decitabine for Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Decitabine for Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Decitabine for Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Decitabine for Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Decitabine for Injection Revenue (2021-2032)
  8. 7.2.2 North America Decitabine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Decitabine for Injection Revenue (2021-2032)
  11. 7.3.2 Europe Decitabine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Decitabine for Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Decitabine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Decitabine for Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Decitabine for Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Astex Pharmaceuticals
  2. 8.1.1 Astex Pharmaceuticals Company Information
  3. 8.1.2 Astex Pharmaceuticals Business Overview
  4. 8.1.3 Astex Pharmaceuticals Decitabine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Astex Pharmaceuticals Decitabine for Injection Product Portfolio
  6. 8.1.5 Astex Pharmaceuticals Recent Developments
  7. 8.2 Hansoh Pharmaceutical
  8. 8.2.1 Hansoh Pharmaceutical Company Information
  9. 8.2.2 Hansoh Pharmaceutical Business Overview
  10. 8.2.3 Hansoh Pharmaceutical Decitabine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hansoh Pharmaceutical Decitabine for Injection Product Portfolio
  12. 8.2.5 Hansoh Pharmaceutical Recent Developments
  13. 8.3 Ingenus Pharmaceutical
  14. 8.3.1 Ingenus Pharmaceutical Company Information
  15. 8.3.2 Ingenus Pharmaceutical Business Overview
  16. 8.3.3 Ingenus Pharmaceutical Decitabine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ingenus Pharmaceutical Decitabine for Injection Product Portfolio
  18. 8.3.5 Ingenus Pharmaceutical Recent Developments
  19. 8.4 Meitheal Pharmaceuticals
  20. 8.4.1 Meitheal Pharmaceuticals Company Information
  21. 8.4.2 Meitheal Pharmaceuticals Business Overview
  22. 8.4.3 Meitheal Pharmaceuticals Decitabine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Meitheal Pharmaceuticals Decitabine for Injection Product Portfolio
  24. 8.4.5 Meitheal Pharmaceuticals Recent Developments
  25. 8.5 Otsuka US
  26. 8.5.1 Otsuka US Company Information
  27. 8.5.2 Otsuka US Business Overview
  28. 8.5.3 Otsuka US Decitabine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Otsuka US Decitabine for Injection Product Portfolio
  30. 8.5.5 Otsuka US Recent Developments
  31. 8.6 Sagent Pharmaceuticals
  32. 8.6.1 Sagent Pharmaceuticals Company Information
  33. 8.6.2 Sagent Pharmaceuticals Business Overview
  34. 8.6.3 Sagent Pharmaceuticals Decitabine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sagent Pharmaceuticals Decitabine for Injection Product Portfolio
  36. 8.6.5 Sagent Pharmaceuticals Recent Developments
  37. 8.7 Huiyu Pharmaceutical
  38. 8.7.1 Huiyu Pharmaceutical Company Information
  39. 8.7.2 Huiyu Pharmaceutical Business Overview
  40. 8.7.3 Huiyu Pharmaceutical Decitabine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Huiyu Pharmaceutical Decitabine for Injection Product Portfolio
  42. 8.7.5 Huiyu Pharmaceutical Recent Developments
  43. 8.8 Qilu Pharmaceutical
  44. 8.8.1 Qilu Pharmaceutical Company Information
  45. 8.8.2 Qilu Pharmaceutical Business Overview
  46. 8.8.3 Qilu Pharmaceutical Decitabine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Qilu Pharmaceutical Decitabine for Injection Product Portfolio
  48. 8.8.5 Qilu Pharmaceutical Recent Developments
  49. 8.9 Xian Janssen Pharmaceutical
  50. 8.9.1 Xian Janssen Pharmaceutical Company Information
  51. 8.9.2 Xian Janssen Pharmaceutical Business Overview
  52. 8.9.3 Xian Janssen Pharmaceutical Decitabine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Xian Janssen Pharmaceutical Decitabine for Injection Product Portfolio
  54. 8.9.5 Xian Janssen Pharmaceutical Recent Developments
  55. 8.10 Chia Tai Tianqing Pharmaceutical Group
  56. 8.10.1 Chia Tai Tianqing Pharmaceutical Group Company Information
  57. 8.10.2 Chia Tai Tianqing Pharmaceutical Group Business Overview
  58. 8.10.3 Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Chia Tai Tianqing Pharmaceutical Group Decitabine for Injection Product Portfolio
  60. 8.10.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Decitabine for Injection Value Chain Analysis
  2. 9.1.1 Decitabine for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Decitabine for Injection Production Mode & Process
  6. 9.2 Decitabine for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Decitabine for Injection Distributors
  9. 9.2.3 Decitabine for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst